NEW YORK, Feb 29 (Reuters) - Pfizer (PFE.N), opens new tab on Thursday said a single dose of its new respiratory syncytial virus (RSV) vaccine Abrysvo maintained its ability to protect against the ...

The Food and Drug Administration on Wednesday approved Pfizer’s vaccine to protect older adults from RSV, weeks after the agency greenlit the very first shot against the common and potentially lethal ...

A third dose of the Pfizer/BioNTech COVID-19 vaccine can "strongly" boost protection against the delta variant -- beyond the protection afforded by the standard two doses, suggests new data released ...

Pfizer's (NYSE:PFE) aim to deliver its respiratory syncytial virus (RSV) to low income countries may hit obstacles and could be delayed by several years, Reuters reported citing global health ...

LONDON, April 28 (Reuters) - Pfizer Inc PFE.N has pledged to deliver critical new medicines more quickly in low-income nations, but its first such vaccine effort faces hurdles likely to delay ...

CLAIM: Pfizer’s COVID-19 vaccine contains a DNA sequence called Simian Virus 40 that can cause health problems, including cancer. THE FACTS: No evidence has been found to suggest DNA fragments used in ...

FILE PHOTO: A woman receives a booster dose of Pfizer-BioNTech vaccine against the coronavirus disease (COVID-19) at the police hospital in Bangkok (Reuters) - Pfizer and German partner BioNTech said ...

A panel of independent experts on Thursday recommended the Food and Drug Administration approve an RSV vaccine by Pfizer designed to protect babies by vaccinating pregnant parents, potentially paving ...